Practice Pitfalls “Everything You Didn’t Know You Needed to Know About Obstructive Sleep Apnea” UT Health San Antonio School of Dentistry September 8. pRESENTED BY gREGORY oSBORNE, dds, d-ABDSM AND Ruben Avalos, MS, LVN, CDP, RDA
When it comes to health, good sleep is just as important as diet and exercise. Learn how a custom-fit, easy-to-use, and FDA-cleared oral appliance can improve both your symptoms and overall quality of life.
THE ACADEMY OF DENTISTRY INTERNATIONAL We are honored to have Dr. Gregory Osborne as one of our confirmed symposium speakers. Dr. Osborne graduated from UTHSCSA School of Dentistry and currently serves as Adjunct Clinical Assistant Professor.
Monday, October 4, 2021, at 6:00 PM Central Would you please join Greg Osborne, DDS, and the Moebius Syndrome Foundation for an informative webinar? We will be discussing primary dental concerns that are common in individuals with Moebius syndrome and an
Presented by: Arthur Feigenbaum, DMD; Belinda Postol, RN; Kevin Postol, DDS; Gregory Osborne, DDS; and Jonathan A. Parker, DDS
Thursday, March 18, 2021
7pm ET/6pm CT/5pm MT/4pm PT
Dental sleep medicine offers the opportunity to treat patients in a variety of practice settings. During this panel discussion, faculty will describe their general dentistry, hospital-based, DSM-only and multidisciplinary practice models while exploring their successes and struggles.
Dentists and team members treating patients with sleep-related breathing disorders.
At the conclusion of this webinar, participants will be able to:
1. Describe various practice models of dental sleep medicine;
2. Consider strategies for improving patient access to oral appliance therapy; and
3. Differentiate pros and cons of various pathways to dental sleep medicine practice growth.
Belinda Postol, RN has been actively involved with her husband's dental practice from its inception in 1995. As the business manager, she is involved with all aspects of the practice. Since 2007, she has been intricately involved with dental sleep medicine, developing protocols and strategies for insurance, communication with sleep physicians, and consultations with patients. She has trained with dental sleep physicians around the country and brings both a thorough knowledge of obstructive sleep apnea and understanding of the medical arena. She has spoken across the country with the AADSM and university-based programs. In addition to working at the dental practice, Belinda had worked at SSM Health Cardinal Glennon Children’s Hospital on a part-time basis until her retirement in June 2019 after 31 years. She continues to expand her knowledge in the areas of sleep and medical insurance.
Kevin Postol, DDS received his dental degree from the University of Missouri-Kansas City and attended the University of Iowa for a General Practice Residency. He has practiced general dentistry since 1992. In 2006, he entered the field of dental sleep medicine and later became a Diplomate of the American Board of Dental Sleep Medicine (ABDSM) in 2011. He is past chairman of the AADSM Essentials of Dental Sleep Medicine course and has spoken at numerous local and national meetings. He currently serves on the Board of Directors of the AADSM. Dr. Postol maintains a combination of a general dental practice and dental sleep medicine practice simultaneously in St. Louis, MO.
Arthur Feigenbaum, DMD is a Diplomate of the American Board of Dental Sleep Medicine. He works full-time in the field of dental sleep medicine with experience in cardiology offices, sleep labs, sleep physician offices and multi-specialty dental offices. Dr. Feigenbaum serves as Director of Dental Sleep Medicine for Delta Sleep Center of Long Island and ProHEALTH Dental. He currently serves as the Vice-Chair of the AADSM Annual Meeting Committee and Secretary of the Queens County Dental Society.
Gregory Osborne, DDS earned his Doctor of Dental Surgery degree from the University of Texas Health Science Center at San Antonio Dental School in 1981, and in 2005 he was appointed as Clinical Faculty Assistant Professor. He has been treating OSA patients with oral appliances for most of his career as a general dentist, but his passion for helping others was ignited when several of his extended family were diagnosed with OSA. He has seen how effective oral appliances can be and how compliance is high even with patients that are intolerant to CPAP therapy. In 2017 he founded Easy Sleep Dentistry, where his practice is limited to the treatment of obstructive sleep apnea, snoring and TMD. He is a Diplomate of the American Board of Dental Sleep Medicine, Fellow of the Academy of General Dentistry International (FADI), and is the Past-President of the Baptist Medical Dental Fellowship, an international healthcare mission organization.
Jonathan A. Parker, DDS is a graduate of the University of Minnesota School of Dentistry. He has been caring for patients with snoring and sleep apnea for over 28 years. He is also a co-founder of the Sleep Performance Institute. He is a Diplomate of the American Board of Dental Sleep Medicine (ABDSM) and the American Board of Orofacial Pain. He is a Past President of the American Board of Dental Sleep Medicine. Dr. Parker is an Adjunct Clinical Professor at Tufts University School of Dental Medicine. He lectures internationally on the dentist’s role in treating OSA.
Obstructive Sleep Apnea Linked With Worse COVID-19
(Reuters) - Obstructive sleep apnea (OSA) appears to put COVID-19 patients at higher risk for critical illness, a new study finds.
Using Finnish national databases, researchers found that while the rates of infection with the new coronavirus were the same for people with and without OSA, among people who did become infected, those with OSA had a five-fold higher risk of hospitalization.
OSA is associated with health problems like obesity, high blood pressure, heart disease, and diabetes, but it was linked with a higher risk for severe COVID-19 even after researchers adjusted for these other factors.
The study cannot prove that OSA caused the more severe outcomes. But in a paper posted on medRxiv ahead of peer review, researchers advise doctors evaluating patients with suspected or confirmed coronavirus infection to recognize that the sleep disorder is a risk factor for severe COVID-19.
SOURCE: https://bit.ly/3nmUDuz medRxiv, online September 28, 2020.
April 17, 2020 Presentation by Dr. Osborne "Sleep Dentistry....Confessions of a Former Dabbler" education program for dentists
Oral Appliance Therapy Should be Prescribed as a First-Line Therapy for OSA during the COVID-19 Pandemic
It is the position of the American Academy of Dental Sleep Medicine (AADSM) that oral appliance therapy (OAT) should be prescribed as a first-line therapy for the treatment of obstructive sleep apnea (OSA) during the COVID-19 pandemic. This recommendation is being made based on the following information:
• The American Academy of Sleep Medicine (AASM) has indicated that PAP therapy potentially exposes individuals, especially those in proximity to the patient, to increased risk of transmission of COVI-19. A number of studies have found evidence that COVID-19 can remain suspended in the air in aerosol particles.
• It is unknown whether it is possible for patients to be re-infected from re-using PAP tubing, filters, and/or masks.
• There have been reported shortages of distilled water and other supplies necessary for optimal use of PAP machines.
• Oral appliances do not generate aerosols and can be easily disinfected by patients to kill the COVID-19 virus.
According to the AADSM and AASM clinical practice guideline, oral appliances should be prescribed for adult patients who prefer alternate therapy to PAP. During this pandemic, it is reasonable to assume that patients would prefer a therapy that both treats their OSA and does not increase the risk of COVID-19 transmission. Oral appliance therapy is an effective treatment for OSA without increased risks for transmitting COVID-19. Patients who prefer OAT may be more likely to adhere to treatment, if they are confident that their therapy is not putting those in their household at an increased risk for COVID-19 exposure. CITATION Schwartz D, Addy N, Levine M, Smith H. Oral appliance therapy should be prescribed as a first-line therapy for OSA during the COVID-19 pandemic. J Dent Sleep Med. 2020;7(3). REFERENCES 1. COVID-19: FAQs for Sleep Clinicians. https://aasm.org/covid-19- resources/covid-19-faq/. Accessed May 8, 2020. 2. Liu, Y., Ning, Z., Chen, Y. et al. Aerodynamic analysis of SARSCoV-2 in two Wuhan hospitals. Nature (2020). https://doi.org/10.1038/s41586-020-2271-3 3. Ramar K, Dort LC, et al. Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015 An American Academy of Sleep Medicine and American Academy of Dental Sleep Medicine Clinical Practice Guideline. J Dent Sleep Med. 2015;2(3). doi:10.15331/jdsm.4868 SUBMISSION AND CORRESPONDENCE INFORMATION Submitted in final revised form May 14, 2020. Address correspondence to: David Schwartz, DDS; Email: email@example.com DISCLOSURE STATEMENT All authors are members of the AADSM Board of Directors Executive Committee. Dr. Schwartz is a consultant of ResMed and has conducted lectures and speaking engagements for SomnoMed and ProSomnus Sleep Technologies.
David Schwartz, DDS1 ; Nancy Addy, DDS2 ; Mitchell Levine, DMD3 ; Harold Smith, DDS4 1North Shore Family Dentistry, Skokie, IL; 2Snoring and Sleep Apnea Dental Treatment Center, Leawood, KS; 3Department of Orthodontics, University of Tennessee Health Science Center, Memphis, Tennessee; 4Dental Sleep Medicine of Indiana, Indianapolis, Indiana